Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 19, 2019
Patent Application Number
15195098
Date Filed
June 28, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided herein are agonistic antibodies, or antigen binding portions thereof, that bind to human CD40. Such antibodies optionally comprise Fc regions with enhanced specificity for FcγRIIb. The invention also provides methods of treatment of cancer or chronic infection by administering the antibodies of the invention to a subject in need thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
